PNC Financial Services Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.1M | Buy |
71,942
+2,517
| +4% | +$1.17M | 0.02% | 357 |
|
|
2025
Q4 | $31.5M | Sell |
69,425
-347
| -0.5% | -$150K | 0.02% | 349 |
|
|
2025
Q3 | $27.3M | Sell |
69,772
-6,384
| -8% | -$2.67M | 0.02% | 367 |
|
|
2025
Q2 | $33.9M | Sell |
76,156
-2,005
| -3% | -$924K | 0.02% | 328 |
|
|
2025
Q1 | $37.9M | Sell |
78,161
-461
| -0.6% | -$215K | 0.02% | 304 |
|
|
2024
Q4 | $31.7M | Sell |
78,622
-807
| -1% | -$374K | 0.02% | 317 |
|
|
2024
Q3 | $36.9M | Buy |
79,429
+4,269
| +6% | +$2.05M | 0.02% | 306 |
|
|
2024
Q2 | $35.2M | Sell |
75,160
-4,794
| -6% | -$2.08M | 0.02% | 305 |
|
|
2024
Q1 | $33.4M | Buy |
79,954
+3,258
| +4% | +$1.38M | 0.02% | 314 |
|
|
2023
Q4 | $31.2M | Buy |
76,696
+2,431
| +3% | +$898K | 0.02% | 311 |
|
|
2023
Q3 | $25.8M | Buy |
74,265
+1,573
| +2% | +$550K | 0.02% | 325 |
|
|
2023
Q2 | $25.6M | Buy |
72,692
+4,480
| +7% | +$1.51M | 0.02% | 341 |
|
|
2023
Q1 | $21.5M | Sell |
68,212
-2,063
| -3% | -$619K | 0.02% | 365 |
|
|
2022
Q4 | $20.3M | Sell |
70,275
-2,328
| -3% | -$710K | 0.02% | 370 |
|
|
2022
Q3 | $21M | Buy |
72,603
+1,248
| +2% | +$359K | 0.02% | 355 |
|
|
2022
Q2 | $20.1M | Buy |
71,355
+191
| +0.3% | +$51.1K | 0.02% | 367 |
|
|
2022
Q1 | $18.6M | Buy |
71,164
+19,627
| +38% | +$4.66M | 0.02% | 407 |
|
|
2021
Q4 | $11.3M | Buy |
51,537
+20,397
| +66% | +$3.97M | 0.01% | 513 |
|
|
2021
Q3 | $5.65M | Buy |
31,140
+1,524
| +5% | +$298K | 0.01% | 629 |
|
|
2021
Q2 | $5.97M | Sell |
29,616
-110
| -0.4% | -$23K | 0.01% | 614 |
|
|
2021
Q1 | $6.39M | Sell |
29,726
-15,956
| -35% | -$3.5M | 0.01% | 577 |
|
|
2020
Q4 | $10.8M | Sell |
45,682
-1,789
| -4% | -$410K | 0.01% | 476 |
|
|
2020
Q3 | $12.9M | Buy |
47,471
+1,575
| +3% | +$435K | 0.02% | 412 |
|
|
2020
Q2 | $13.3M | Buy |
45,896
+21,649
| +89% | +$5.87M | 0.02% | 397 |
|
|
2020
Q1 | $5.77M | Buy |
24,247
+857
| +4% | +$197K | 0.01% | 516 |
|
|
2019
Q4 | $5.12M | Buy |
23,390
+33
| +0.1% | +$6.68K | 0.01% | 603 |
|
|
2019
Q3 | $3.96M | Sell |
23,357
-1,636
| -7% | -$289K | ﹤0.01% | 723 |
|
|
2019
Q2 | $4.58M | Sell |
24,993
-1,042
| -4% | -$182K | ﹤0.01% | 731 |
|
|
2019
Q1 | $4.79M | Buy |
26,035
+1,200
| +5% | +$222K | ﹤0.01% | 727 |
|
|
2018
Q4 | $4.12M | Sell |
24,835
-6,915
| -22% | -$1.2M | ﹤0.01% | 743 |
|
|
2018
Q3 | $6.12M | Buy |
31,750
+8,707
| +38% | +$1.55M | 0.01% | 698 |
|
|
2018
Q2 | $3.92M | Sell |
23,043
-1,825
| -7% | -$283K | ﹤0.01% | 830 |
|
|
2018
Q1 | $4.05M | Buy |
24,868
+1,108
| +5% | +$181K | ﹤0.01% | 797 |
|
|
2017
Q4 | $3.56M | Sell |
23,760
-2,145
| -8% | -$318K | ﹤0.01% | 847 |
|
|
2017
Q3 | $3.94M | Buy |
25,905
+3,419
| +15% | +$515K | ﹤0.01% | 790 |
|
|
2017
Q2 | $2.9M | Buy |
22,486
+1,486
| +7% | +$179K | ﹤0.01% | 869 |
|
|
2017
Q1 | $2.3M | Buy |
21,000
+3,527
| +20% | +$311K | ﹤0.01% | 956 |
|
|
2016
Q4 | $1.29M | Sell |
17,473
-6,660
| -28% | -$542K | ﹤0.01% | 1170 |
|
|
2016
Q3 | $2.1M | Buy |
24,133
+3,069
| +15% | +$290K | ﹤0.01% | 962 |
|
|
2016
Q2 | $1.81M | Buy |
21,064
+4,179
| +25% | +$361K | ﹤0.01% | 986 |
|
|
2016
Q1 | $1.34M | Buy |
16,885
+3,182
| +23% | +$288K | ﹤0.01% | 1127 |
|
|
2015
Q4 | $1.73M | Sell |
13,703
-22,583
| -62% | -$2.73M | ﹤0.01% | 970 |
|
|
2015
Q3 | $3.78M | Buy |
36,286
+1,039
| +3% | +$133K | ﹤0.01% | 706 |
|
|
2015
Q2 | $4.35M | Sell |
35,247
-825
| -2% | -$104K | ﹤0.01% | 709 |
|
|
2015
Q1 | $4.26M | Buy |
36,072
+2,061
| +6% | +$247K | ﹤0.01% | 709 |
|
|
2014
Q4 | $4.04M | Buy |
34,011
+5,988
| +21% | +$674K | ﹤0.01% | 715 |
|
|
2014
Q3 | $3.15M | Buy |
28,023
+13,111
| +88% | +$1.25M | ﹤0.01% | 764 |
|
|
2014
Q2 | $1.41M | Sell |
14,912
-430
| -3% | -$30.2K | ﹤0.01% | 978 |
|
|
2014
Q1 | $1.08M | Sell |
15,342
-2,329
| -13% | -$184K | ﹤0.01% | 1040 |
|
|
2013
Q4 | $1.31M | Sell |
17,671
-3,309
| -16% | -$230K | ﹤0.01% | 947 |
|
|
2013
Q3 | $1.59M | Buy |
20,980
+2,838
| +16% | +$226K | ﹤0.01% | 871 |
|
|
2013
Q2 | $1.45M | Buy |
+18,142
| New | +$1.34M | ﹤0.01% | 874 |
|
Other funds holding VRTX
VCM
VPM
PNC Financial Services Group's VRTX Position: Q1 2026 in Review
PNC Financial Services Group increased its Vertex Pharmaceuticals (VRTX) stake by 3.6% in Q1 2026, buying an estimated $1.17M and bringing the position to 71,942 shares worth $32.1M. The position accounts for 0.02% of the portfolio, ranked #357.
PNC Financial Services Group first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.9M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- PNC Financial Services Group held 71,942 shares of Vertex Pharmaceuticals worth $32.1M as of Q1 2026.
- PNC Financial Services Group bought 2,517 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.17M.
- Vertex Pharmaceuticals made up 0.02% of PNC Financial Services Group's portfolio in Q1 2026, its #357 holding.
- PNC Financial Services Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- PNC Financial Services Group's Vertex Pharmaceuticals position peaked at $37.9M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.